● 45th Parliament — 1st session   ● recorded nominal votes   ● bills tracked   ● bills challenged by citizens   ● independent citizen-run site · real public data    ● 45th Parliament — 1st session   ● recorded nominal votes   ● bills tracked   ● bills challenged by citizens   ● independent citizen-run site · real public data   
BCABSKMBONQCNBNSPENL
DossierCanada
QCNBNSPENL
100%
FR
Who sits, who legislates, who votes how

DossierCanada — who sits and votes in Canada's Parliament

Challenged bills

✋ Challenge a bill

Recently active bills

See all →

Federal MPs

Who represents you, how they vote, how often they sit.

The federal Cabinet

Who decides what, since when, and how they vote.
Up to date. These ministers come directly from the official Cabinet page on pm.gc.ca, scraped live — not a hand-maintained list.

C-265 — An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)

Every bill summarized in plain language. Not clear enough? Ask for an explanation.
All statusesIn progressDefeatedAssented to
House of CommonsSenateLobbying 43Omnibus 13
C-265 An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access) 5 LPC In progress ▾
BILL C-265

An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)

Last activity : At consideration in committee in the House of Commons
Private Member’s Bill · Sponsor : Marcus Powlowski
LPC In progress
Sponsor : Marcus Powlowski · House of Commons · Private Member’s Bill
Commons · 1st2026-03-11Commons · 2nd2026-06-10Commons · 3rdSenate · 1stSenate · 2ndSenate · 3rdRoyal assent
− Hide summary
What it does, in plain language
  • Creates a "List of Therapeutic Products Pre-approved for Special Access" that the Minister of Health must build, maintain and post on the Health Canada website, covering non-marketed products used to treat serious or life-threatening conditions, including rare diseases.
  • Sets out what can go on the list: products that previously held an authorization not cancelled for safety reasons, products approved by a foreign regulator the Minister considers comparable, or new drugs already covered by a letter of authorization.
  • Requires the Minister to consult a non-partisan committee of medical research and clinical experts, including specialists working with children, before creating or changing the list; members serve unpaid and without expense reimbursement.
  • Lets practitioners, pharmacists, hospitals or medical non-profits nominate a product for the list, with the Minister required to decide within 120 days.
  • Allows a practitioner to order a listed product directly from the manufacturer for a patient, with a report to the Minister due within 90 days; manufacturers and importers must also notify the Minister of sales and imports within 90 days.
  • Sets rules for emergency letters of authorization for new drugs: evaluation criteria, published guidelines, written reasons for any refusal, and a ban on refusing solely for certain reasons, such as an ongoing clinical trial.
  • Permits a doctor, in an emergency, to temporarily give a product based on clinical judgment without prior authorization, requires Health Canada to keep a help line staffed at all times, mandates annual public reports, and takes effect one year after royal assent.

🤖 AI-generated from the bill’s official text as introduced — may not reflect amendments adopted since.

Registered lobbying 5 communications · 1 organization as of Sep 10, 2026 the 5 most recent +
Canadian Organization for Rare Disorders5

✋ What does “challenging” mean?

Clicking “Ask for an explanation” is a citizen request for the bill's sponsor to explain it in plain language — and for us to keep an eye on it together.

An account (email) is required — one request per person, no anonymous requests. 🔥 At 1,000 requests on the same bill, a public post is made, in the hope an MP agrees to sponsor a petition to the House.

It works on any bill, including one that has already received royal assent — that is often the one people want to understand.

Votes in the Commons

Every recorded vote — who voted what, and by what margin.
On the “who voted what” detail — the House of Commons publishes each member's name for every recorded (nominal) vote (Yea / Nay / paired). The by-member breakdown above (the "+" button on each row) comes directly from that official source (ourcommons.ca), not an estimate. The party shown next to each name is taken from the current House roster; people who have since left the House appear separately under "Former members".

How to read a vote

Recorded vote

Members vote one by one and each choice is entered in the public record. That is what lets us say exactly who voted what — no interpretation.

Passed is not law

A passed vote clears ONE stage. A bill must pass both chambers and then receive royal assent before it becomes law.

Paired is not absent

In the Commons, two members from opposing sides can agree not to vote: their voices cancel out. It is neither an absence nor an abstention.

DossierCanada updates

What changed on the site, newest first
← Back to overview
Martin Archambault
Hi! My name is Martin Archambault I'm 45, and dossiercanada.ca is your first step into democracy!

If we want people to understand politics, it has to be brought down to their level.

When I first tried to take an interest in it, on top of not knowing the jargon, bills came as two lines… and fifty PDFs. Most people would simply walk away.

So I had an idea: use artificial intelligence first to read through all of it, then to put it in plain words. That's how DossierCanada was born.

Alongside the AI recap, I've given people a lexicon that explains the basics of political jargon. Plain-language law exists — think of this as its equivalent for politics!

Parliament glossary

Parliamentary jargon, translated into everyday language.
Account and follows